Gujarat Kidney and Super Speciality IPO

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.

The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.

The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).

Services:

• Secondary Care Services: General and surgical treatments.
  
  
• Tertiary Care Services: Super speciality surgical procedures.
  
  

Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.

As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.

Competitive Strengths:

• Pre-eminence in renal sciences, with established sub-superspecialities in urology
• Asset light business model with focus in central region of Gujarat
• Ability to attract, retain skilled and experienced quality medical professionals
• Track record of operating and financial performance and growth